# AtriCure, Inc.: filings

ATRC · Nasdaq · CIK 1323885 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/atrc.md) · [Financials](/companies/atrc/financials.md) · [Filings](/companies/atrc/filings.md) · [Insiders](/companies/atrc/insiders.md)

## Reports and events: 263 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 805, 8-K 155, SC 13G/A 63, 10-Q 53, 144 36, 3 23, S-8 23, DEF 14A 19, 10-K 18, DEFA14A 18, SC 13G 14, SD 13, 424B5 8, 8-K/A 7, ARS 7, EFFECT 7, SC 13D/A 7, SCHEDULE 13G/A 7, SCHEDULE 13G 6, POS AM 4, S-3ASR 4, SC 13D 4, UPLOAD 4, 3/A 3, 424B3 3, 4/A 3, CORRESP 3, S-3 3, S-3/A 2, 424B7 1, 5 1, POSASR 1, PRE 14A 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-07-27 | 13:07 ET | [10-Q](/filings/0001323885-26-000035.md) | Quarterly report, period 2026-06-30 | 0001323885-26-000035 |
| 2026-07-23 | 16:00 ET | [8-K](/filings/0001323885-26-000032.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001323885-26-000032 |
| 2026-05-19 | 16:21 ET | [8-K](/filings/0001323885-26-000025.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001323885-26-000025 |
| 2026-05-06 | 12:31 ET | [10-Q](/filings/0001323885-26-000023.md) | Quarterly report, period 2026-03-31 | 0001323885-26-000023 |
| 2026-05-06 | 21:01 ET | [8-K/A](/filings/0001323885-26-000020.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001323885-26-000020 |
| 2026-05-05 | 16:00 ET | [8-K](/filings/0001323885-26-000018.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001323885-26-000018 |
| 2026-04-06 | 11:54 ET | [DEF 14A](/filings/0001323885-26-000010.md) | Proxy statement, period 2026-04-06 | 0001323885-26-000010 |
| 2026-02-19 | 12:39 ET | [10-K](/filings/0001323885-26-000007.md) | Annual report, period 2025-12-31 | 0001323885-26-000007 |
| 2026-02-17 | 16:00 ET | [8-K](/filings/0001323885-26-000005.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001323885-26-000005 |
| 2026-01-12 | 08:00 ET | [8-K](/filings/0001193125-26-009814.md) | 1.01 Entry into a material agreement; 2.02 Results of operations; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-26-009814 |
| 2025-10-30 | 12:21 ET | [10-Q](/filings/0001323885-25-000103.md) | Quarterly report, period 2025-09-30 | 0001323885-25-000103 |
| 2025-10-29 | 17:18 ET | [8-K/A](/filings/0001323885-25-000101.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001323885-25-000101 |
| 2025-10-29 | 16:00 ET | [8-K](/filings/0001323885-25-000098.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001323885-25-000098 |
| 2025-07-30 | 12:34 ET | [10-Q](/filings/0001323885-25-000095.md) | Quarterly report, period 2025-06-30 | 0001323885-25-000095 |
| 2025-07-29 | 16:00 ET | [8-K](/filings/0001323885-25-000092.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001323885-25-000092 |
| 2025-05-20 | 16:29 ET | [8-K](/filings/0001323885-25-000050.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001323885-25-000050 |
| 2025-04-30 | 13:06 ET | [10-Q](/filings/0001323885-25-000043.md) | Quarterly report, period 2025-03-31 | 0001323885-25-000043 |
| 2025-04-29 | 16:00 ET | [8-K](/filings/0001323885-25-000041.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001323885-25-000041 |
| 2025-04-07 | 16:03 ET | [DEF 14A](/filings/0001323885-25-000037.md) | Proxy statement, period 2025-04-07 | 0001323885-25-000037 |
| 2025-03-26 | 13:00 ET | [8-K](/filings/0001323885-25-000033.md) | 7.01 Regulation FD disclosure | 0001323885-25-000033 |
| 2025-02-14 | 13:39 ET | [10-K](/filings/0001323885-25-000009.md) | Annual report, period 2024-12-31 | 0001323885-25-000009 |
| 2025-02-12 | 16:00 ET | [8-K](/filings/0001323885-25-000005.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001323885-25-000005 |
| 2025-01-13 | 08:00 ET | [8-K](/filings/0001323885-25-000002.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001323885-25-000002 |
| 2024-10-30 | 11:49 ET | [10-Q](/filings/0001323885-24-000117.md) | Quarterly report, period 2024-09-30 | 0001323885-24-000117 |
| 2024-10-29 | 16:01 ET | [8-K](/filings/0001323885-24-000115.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001323885-24-000115 |
| 2024-07-31 | 11:39 ET | [10-Q](/filings/0001323885-24-000106.md) | Quarterly report, period 2024-06-30 | 0001323885-24-000106 |
| 2024-07-30 | 16:00 ET | [8-K](/filings/0001323885-24-000104.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001323885-24-000104 |
| 2024-05-14 | 16:52 ET | [8-K](/filings/0001323885-24-000068.md) | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001323885-24-000068 |
| 2024-05-02 | 11:15 ET | [10-Q](/filings/0001323885-24-000062.md) | Quarterly report, period 2024-03-31 | 0001323885-24-000062 |
| 2024-05-01 | 16:00 ET | [8-K](/filings/0001323885-24-000060.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001323885-24-000060 |
| 2024-04-03 | 17:05 ET | [DEF 14A](/filings/0001323885-24-000055.md) | Proxy statement, period 2024-04-03 | 0001323885-24-000055 |
| 2024-02-27 | 08:50 ET | [8-K/A](/filings/0001323885-24-000020.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001323885-24-000020 |
| 2024-02-16 | 14:10 ET | [10-K](/filings/0001323885-24-000016.md) | Annual report, period 2023-12-31 | 0001323885-24-000016 |
| 2024-02-15 | 16:00 ET | [8-K](/filings/0001323885-24-000013.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001323885-24-000013 |
| 2024-01-08 | 08:00 ET | [8-K](/filings/0001193125-24-003922.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.02 Results of operations; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-24-003922 |
| 2024-01-04 | 08:00 ET | [8-K](/filings/0001323885-24-000004.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001323885-24-000004 |
| 2023-11-02 | 12:17 ET | [10-Q](/filings/0001323885-23-000110.md) | Quarterly report, period 2023-09-30 | 0001323885-23-000110 |
| 2023-11-01 | 16:01 ET | [8-K](/filings/0001323885-23-000107.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001323885-23-000107 |
| 2023-07-26 | 13:42 ET | [10-Q](/filings/0001323885-23-000097.md) | Quarterly report, period 2023-06-30 | 0001323885-23-000097 |
| 2023-07-25 | 16:00 ET | [8-K](/filings/0001323885-23-000094.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001323885-23-000094 |
| 2023-05-26 | 11:51 ET | [8-K](/filings/0001323885-23-000053.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0001323885-23-000053 |
| 2023-05-03 | 12:32 ET | [10-Q](/filings/0001323885-23-000047.md) | Quarterly report, period 2023-03-31 | 0001323885-23-000047 |
| 2023-05-02 | 16:01 ET | [8-K](/filings/0001323885-23-000045.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001323885-23-000045 |
| 2023-04-10 | 15:17 ET | [DEF 14A](/filings/0001323885-23-000039.md) | Proxy statement | 0001323885-23-000039 |
| 2023-02-22 | 13:07 ET | [10-K](/filings/0001323885-23-000015.md) | Annual report, period 2022-12-31 | 0001323885-23-000015 |
| 2023-02-21 | 16:02 ET | [8-K](/filings/0001323885-23-000012.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001323885-23-000012 |
| 2023-01-09 | 08:00 ET | [8-K](/filings/0001323885-23-000008.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001323885-23-000008 |
| 2022-11-02 | 13:56 ET | [10-Q](/filings/0001323885-22-000116.md) | Quarterly report, period 2022-09-30 | 0001323885-22-000116 |
| 2022-11-01 | 16:01 ET | [8-K](/filings/0001323885-22-000113.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001323885-22-000113 |
| 2022-08-03 | 14:12 ET | [10-Q](/filings/0001323885-22-000101.md) | Quarterly report, period 2022-06-30 | 0001323885-22-000101 |

Page 1 of 6. [Older](/companies/atrc/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 30, 2026, 13:40 ET. No prices; not investment advice.